X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
humans (8) 8
case report (5) 5
female (5) 5
lung cancer (5) 5
lung neoplasms - drug therapy (5) 5
male (5) 5
oncology (5) 5
tumors (5) 5
aged (4) 4
chemotherapy (4) 4
epidermal growth factor (4) 4
medicine, general & internal (4) 4
patients (4) 4
tyrosine (4) 4
adult (3) 3
cancer therapies (3) 3
cisplatin (3) 3
epidermal growth factor receptors (3) 3
erlotinib (3) 3
gefitinib (3) 3
gene-mutations (3) 3
lymphomas (3) 3
middle aged (3) 3
non-small cell lung carcinoma (3) 3
protein-tyrosine kinase (3) 3
19-g flexible needle (2) 2
afatinib (2) 2
aged, 80 and over (2) 2
analysis (2) 2
animals (2) 2
antineoplastic agents - therapeutic use (2) 2
apoptosis (2) 2
biopsy (2) 2
cancer (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - secondary (2) 2
case reports (2) 2
cell line, tumor (2) 2
cisplatin - administration & dosage (2) 2
clinical trials (2) 2
drug dosages (2) 2
endobronchial ultrasound-guided transbronchial needle aspiration (2) 2
kinases (2) 2
lung neoplasms - complications (2) 2
lung neoplasms - pathology (2) 2
lymphatic metastasis (2) 2
medicine (2) 2
medicine & public health (2) 2
metastasis (2) 2
mice, nude (2) 2
multidisciplinary sciences (2) 2
mutation (2) 2
neoplasm staging (2) 2
nsclc (2) 2
open-label (2) 2
osimertinib (2) 2
patient selection (2) 2
prospective studies (2) 2
protein kinase inhibitors - pharmacology (2) 2
receptor, epidermal growth factor - antagonists & inhibitors (2) 2
research article (2) 2
respiratory tract diseases (2) 2
science (2) 2
squamous cell carcinoma (2) 2
surgical oncology (2) 2
ultrasonic imaging (2) 2
1st-line therapy (1) 1
1st-line treatment (1) 1
acquired resistance (1) 1
acquired-resistance (1) 1
acute kidney injury - chemically induced (1) 1
acute kidney injury - prevention & control (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenoid cystic carcinoma (1) 1
adverse events (1) 1
airway hyper-responsiveness (1) 1
alk rearrangement-positive nsclc (1) 1
allergic (1) 1
ampicillin (1) 1
anemia (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anti-vegf treatment (1) 1
antibiotics (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents, immunological - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
article (1) 1
association (1) 1
asthma (1) 1
autoimmune hemolytic anemia (1) 1
azd9291 (1) 1
benralizumab (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1955 - 11
Journal Article
Journal Article
Respirology Case Reports, ISSN 2051-3380, 01/2019, Volume 7, Issue 1, pp. e00388 - n/a
A 64‐year‐old woman, who had presented with a 30‐year history of refractory asthma, and been treated with anti‐allergic drug therapy, inhaled corticosteroids,... 
asthma | omalizumab | eosinophilic | benralizumab | Allergic | Drug therapy | Asthma
Journal Article
Journal Article
Respirology Case Reports, ISSN 2051-3380, 07/2019, Volume 7, Issue 5, pp. e00427 - n/a
A 46‐year‐old male with a superior mediastinal mass presented with a one‐month history of hoarseness and chest pain and was referred to our hospital. Although... 
superior mediastinal tumour | BF‐UC290F | endoscopic, ultrasound‐guided, bronchoscopic fine‐needle aspiration | Ultrasonic imaging | Intubation | Endoscopy | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, p. e0121211
Background In evaluation of the clinical benefit of a new targeted agent in a phase 3 trial enrolling molecularly selected patients with advanced non-small... 
1ST-LINE TREATMENT | MULTICENTER | GEFITINIB | CISPLATIN | MULTIDISCIPLINARY SCIENCES | III TRIALS | OPEN-LABEL | TIME | AFATINIB | CHEMOTHERAPY | ERLOTINIB | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - pathology | Treatment Outcome | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Carcinoma, Non-Small-Cell Lung - mortality | Patient Selection | Clinical Trials, Phase III as Topic | Protein Kinase Inhibitors - therapeutic use | Survival Analysis | Biomarkers | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Odds Ratio | Medical research | Chemotherapy | Analysis | Medicine, Experimental | Lung cancer, Small cell | Lung cancer, Non-small cell | Cancer | Identification methods | Lung cancer | Clinical trials | Cytotoxicity | Oncology | Systematic review | Metastasis | Cancer therapies | Ethics | Epidermal growth factor | Protein-tyrosine kinase | Tyrosine | Cell survival | Hematology | Epidermal growth factor receptors | Non-small cell lung carcinoma | Survival | Patients | Medicine | Studies | Sensitivity | Hospitals | Response rates | Lymphomas | Mutation
Journal Article
Lung Cancer, ISSN 0169-5002, 10/2019, Volume 136, pp. 86 - 93
Lung cancers harboring ( ) mutations inevitably develop resistance to EGFR tyrosine-kinase inhibitors (EGFR-TKIs). Therefore, we sought to establish clinically... 
Osimertinib | EGFR mutations | Acquired resistance | NSCLC | Transgenic mice | Tyrosine | Genetic aspects | Epidermal growth factor | Analysis
Journal Article
Internal Medicine, ISSN 0918-2918, 2019
Objective Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive procedure for pulmonary and mediastinal... 
endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) | 19-G flexible needle
Journal Article
Molecular Oncology, ISSN 1574-7891, 06/2017, Volume 11, Issue 6, pp. 670 - 681
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have changed the treatment strategy for EGFR‐mutant lung cancers; however, resistance... 
deep remission | bevacizumab | afatinib | cetuximab | EGFR T790M | Deep remission | Afatinib | Cetuximab | Bevacizumab | GENE-MUTATIONS | GEFITINIB | ACQUIRED-RESISTANCE | OPEN-LABEL | ANTI-VEGF TREATMENT | CHEMOTHERAPY | GROWTH-FACTOR RECEPTOR | INHIBITION | ONCOLOGY | 1ST-LINE THERAPY | ERLOTINIB | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Bevacizumab - therapeutic use | Humans | Platelet Endothelial Cell Adhesion Molecule-1 - analysis | Drug Resistance, Neoplasm | Cetuximab - therapeutic use | Adenocarcinoma - drug therapy | Remission Induction | Xenograft Model Antitumor Assays | Animals | Antineoplastic Agents, Immunological - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Quinazolines - therapeutic use | Angiogenesis Inhibitors - therapeutic use | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Female | Adenocarcinoma - genetics | Mice | Mutation | Apoptosis | Laboratories | Toxicity | Lung cancer | Body weight | Clinical trials | Body weight loss | Kinases | Cancer therapies | Vascularization | Epidermal growth factor | Xenografts | Conflicts of interest | Remission | Vascular endothelial growth factor | Drug dosages | Protein-tyrosine kinase | Tyrosine | Immunoglobulins | Epidermal growth factor receptors | Caspase | Grants | Endothelial cells | Chemotherapy | Pharmaceuticals | Tumors | Index Medicus
Journal Article
Internal Medicine, ISSN 0918-2918, 2012, Volume 51, Issue 19, pp. 2767 - 2770
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e19084 - e19084
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.